The probable mechanism of action involves a combination of cholinesterase inhibition, direct free radical scavenging, and modulation of endogenous antioxidant systems, leading to reduced oxidative damage and preservation of cholinergic neurotransmission—all of which are key targets in neurodegenerative conditions like AD. This evidence concerns the gene BCHE and Alzheimer disease.